Lammi Carmen, Aiello Gilda, Bollati Carlotta, Li Jianqiang, Bartolomei Martina, Ranaldi Giulia, Ferruzza Simonetta, Fassi Enrico Mario Alessandro, Grazioso Giovanni, Sambuy Yula, Arnoldi Anna
Department of Pharmaceutical Sciences, University of Milan, 20122 Milan, Italy.
Department of Human Science and Quality of Life Promotion, Telematic University San Raffaele, 00166 Rome, Italy.
Nutrients. 2021 Mar 5;13(3):863. doi: 10.3390/nu13030863.
P5 (LILPKHSDAD) is a hypocholesterolemic peptide from lupin protein with a multi-target activity, since it inhibits both 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCoAR) and proprotein convertase subtilisin/kexin type-9 (PCSK9). This work shows that, during epithelial transport experiments, the metabolic transformation mediated by intestinal peptidases produces two main detected peptides, ILPKHSDAD (P5-frag) and LPKHSDAD (P5-met), and that both P5 and P5-met are linearly absorbed by differentiated human intestinal Caco-2 cells. Extensive comparative structural, biochemical, and cellular characterizations of P5-met and the parent peptide P5 demonstrate that both peptides have unique characteristics and share the same mechanisms of action. In fact, they exert an intrinsically multi-target behavior being able to regulate cholesterol metabolism by modulating different pathways. The results of this study also highlight the dynamic nature of bioactive peptides that may be modulated by the biological systems they get in contact with.
P5(LILPKHSDAD)是一种来自羽扇豆蛋白的具有多靶点活性的降胆固醇肽,因为它既能抑制3-羟基-3-甲基戊二酰辅酶A还原酶(HMGCoAR),又能抑制前蛋白转化酶枯草杆菌蛋白酶/kexin 9型(PCSK9)。这项研究表明,在上皮转运实验中,肠道肽酶介导的代谢转化产生了两种主要检测到的肽,ILPKHSDAD(P5-片段)和LPKHSDAD(P5-代谢物),并且P5和P5-代谢物都能被分化的人肠道Caco-2细胞线性吸收。对P5-代谢物和母体肽P5进行广泛的比较结构、生化和细胞表征表明,这两种肽都具有独特的特性并共享相同的作用机制。事实上,它们具有内在的多靶点行为,能够通过调节不同途径来调节胆固醇代谢。这项研究的结果还突出了生物活性肽的动态性质,它们可能会受到与之接触的生物系统的调节。